Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Ovarian Cancer Recurrent
×
Clear all
Filters
2
NCT01332656
2015-12-21
OPSALIN
Sanofi
Phase 2
Completed
154 enrolled
NCT01485848
2014-06-10
ESP2011-002
Esperance Pharmaceuticals Inc
Phase 2
Completed
49 enrolled